Date(s) - 02 June, 2018
10:00 - 18:00
Academisch-cultureel centrum SPUI25
Categories No Categories
On June 2nd, our research/academic friends at the Amsterdam Psychedelic Research Association (APRA) invite you to their first multidisciplinary symposium on contemporary psychedelic research.
6 international speakers from universities in Oxford, London, Paris, Berlin and the Netherlands, will share their most recent findings and perspectives for the future of this field.
• Dr. Selen Atasoy, (University of Oxford), researches brain dynamics in consciousness, sleep, meditation, psychedelic states as well as in psychiatric disorders. She will discuss findings from fMRI analysis of LSD and placebo conditions within the mathematical framework of “connectome harmonics”. (http://www.selenatasoy.com/bio/)
• Christopher Timmermann, (Imperial College London) is currently leading a study on the neurophysiological and subjective effects of DMT, in the pioneering Psychedelic Research Group of Prof. David Nutt and Dr. Robin Carhart-Harris. (https://www.researchgate.net/profile/Christopher_Timmermann)
• Dr. Timo Torsten Schmidt, (Freie Universitat Berlin) focuses on the mental representation of consciousness content, and mechanisms underlying altered states of consciousness. Developer of the “Altered States Database”, an open-science platform with data from hundreds of psychophysiological reports of altered states of consciousness. (http://titoschmi.de/) (http://www.asdb.info/)
• Dr. Tijmen Bostoen, (Leiden University Medical Center) is a Dutch psychiatrist, leading the first clinical trial of MDMA-assisted psychotherapy for PTSD in the Netherlands. He will discuss psychedelics’ mechanisms of action in relation to clinical applications.
• Martin Fortier, (Insititut Nicod, Universitè Paris-Sorbonne) will conclude the symposium with a talk on the anthropological, cognitive, and philosophical implications of contemporary psychedelic research. (http://institutnicod.academia.edu/MartinFortier)
Practical information & Full Description:
The symposium will take place at the beautiful venue of the Academisch-cultureel centrum SPUI 25 (Spui 25, 1012 WX Amsterdam) and last approximately from 10:00 to 18:00, with breaks between lectures and for lunch.
If you choose a student ticket option, you will be asked for a valid student card at the door. If you would like to request any other special arrangements or have any questions, please contact us directly.
After nearly 50 years of academic prohibition, a renewed interest for psychedelics in the scientific and medical communities is driven by state-of the art neuroimaging techniques and striking clinical applications. What more can psychedelics tell us about brain function? How can altered states of consciousness yield therapeutic benefits? Join the symposium to find out!
We use the generic designation “psychedelic” here loosely, as an umbrella term to indicate substances and practices that show intriguing promise for therapy and scientific value, but have suffered an impaired research development because of their legal status or psychoactive effects. Most notably, this definition includes classical serotonergic psychedelics (e.g. psilocybin, mescaline, LSD, DMT), cannabis, MDMA; but also non-pharmacological means to induce altered states of consciousness (e.g. Ganzfeld experiments).
We would like to thank Psychedelic Society of the Netherlands for their continued support, Academisch-Cultureel Centrum SPUI 25 for hosting the event in their beautiful venue, and Alex Anvil of Manifacto Amsterdam for providing the ticket design artwork.
Amsterdam Psychedelic Research Association – APRA